{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:18:56Z","timestamp":1783073936816,"version":"3.54.6"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172659"],"award-info":[{"award-number":["82172659"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46674-9","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T07:25:20Z","timestamp":1775201120000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TMEM184A promotes progression and drug resistance in colorectal cancer: a bioinformatics and clinical study"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9025-6748","authenticated-orcid":false,"given":"Xueliang","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohai","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongping","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0180-8610","authenticated-orcid":false,"given":"Yanfeng","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,3]]},"reference":[{"issue":"3","key":"46674_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"H Sung","year":"2024","unstructured":"Sung, H. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"2 D","key":"46674_CR2","doi-asserted-by":"publisher","first-page":"e240029","DOI":"10.6004\/jnccn.2024.0029","volume":"22","author":"AB NBenson","year":"2024","unstructured":"NBenson, A. B. et al. Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Canc Netw. 22 (2 D), e240029. https:\/\/doi.org\/10.6004\/jnccn.2024.0029 (2024).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"6","key":"46674_CR3","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson, A. B. et al. NCCN Guidelines\u00ae Insights: Rectal Cancer, Version 3.2024. J. Natl. Compr. Canc Netw. 22 (6), 366\u2013375. https:\/\/doi.org\/10.6004\/jnccn.2024.0041 (2024).","journal-title":"J. Natl. Compr. Canc Netw."},{"issue":"25","key":"46674_CR4","doi-asserted-by":"publisher","first-page":"e2301088","DOI":"10.1002\/advs.202301088","volume":"10","author":"K Zeng","year":"2023","unstructured":"Zeng, K. et al. Inhibition of CDK1 Overcomes Oxaliplatin Resistance by Regulating ACSL4-mediated Ferroptosis in Colorectal Cancer. Adv. Sci. (Weinh). 10 (25), e2301088. https:\/\/doi.org\/10.1002\/advs.202301088 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"46674_CR5","doi-asserted-by":"publisher","first-page":"118741","DOI":"10.1016\/j.biopha.2025.118741","volume":"193","author":"S Favier","year":"2025","unstructured":"Favier, S. et al. Exploring and bypassing resistance to targeted therapies in colorectal cancer. Biomed. Pharmacother. 193, 118741. https:\/\/doi.org\/10.1016\/j.biopha.2025.118741 (2025).","journal-title":"Biomed. Pharmacother"},{"issue":"4","key":"46674_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","volume":"60","author":"MJ O\u2019Connor","year":"2015","unstructured":"O\u2019Connor, M. J. Targeting the DNA Damage Response in Cancer. Mol. Cell. 60 (4), 547\u2013560. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.040 (2015).","journal-title":"Mol. Cell."},{"issue":"12","key":"46674_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","volume":"25","author":"KB Kennel","year":"2025","unstructured":"Kennel, K. B. & Greten, F. R. The immune microenvironment of colorectal cancer. Nat. Rev. Cancer. 25 (12), 945\u2013964. https:\/\/doi.org\/10.1038\/s41568-025-00872-1 (2025).","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"46674_CR8","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.molcel.2017.01.023","volume":"65","author":"C Ziegenhain","year":"2017","unstructured":"Ziegenhain, C. et al. Comparative Analysis of Single-Cell RNA Sequencing Methods. Mol. Cell. 65 (4), 631\u2013643e4. https:\/\/doi.org\/10.1016\/j.molcel.2017.01.023 (2017).","journal-title":"Mol. Cell."},{"issue":"1","key":"46674_CR9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2017.76","volume":"18","author":"E Papalexi","year":"2018","unstructured":"Papalexi, E. & Satija, R. Single-cell RNA sequencing to explore immune cell heterogeneity. Nat. Rev. Immunol. 18 (1), 35\u201345. https:\/\/doi.org\/10.1038\/nri.2017.76 (2018).","journal-title":"Nat. Rev. Immunol."},{"issue":"6282","key":"46674_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352 (6282), 189\u2013196. https:\/\/doi.org\/10.1126\/science.aad0501 (2016).","journal-title":"Science"},{"issue":"10","key":"46674_CR11","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1074\/jbc.M115.681122","volume":"291","author":"RJ Pugh","year":"2016","unstructured":"Pugh, R. J. et al. Transmembrane Protein 184A Is a Receptor Required for Vascular Smooth Muscle Cell Responses to Heparin. J. Biol. Chem. 291 (10), 5326\u20135341. https:\/\/doi.org\/10.1074\/jbc.M115.681122 (2016).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"46674_CR12","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1074\/jbc.M115.681288","volume":"291","author":"SL Farwell","year":"2016","unstructured":"Farwell, S. L. et al. Heparin Decreases in Tumor Necrosis Factor \u03b1 (TNF\u03b1)-induced Endothelial Stress Responses Require Transmembrane Protein 184A and Induction of Dual Specificity Phosphatase 1. J. Biol. Chem. 291 (10), 5342\u20135354. https:\/\/doi.org\/10.1074\/jbc.M115.681288 (2016).","journal-title":"J. Biol. Chem."},{"issue":"21","key":"46674_CR13","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1111\/jcmm.17572","volume":"26","author":"Y Lin","year":"2022","unstructured":"Lin, Y. et al. TMEM184B promotes proliferation, migration and invasion, and inhibits apoptosis in hypopharyngeal squamous cell carcinoma. J. Cell. Mol. Med. 26 (21), 5551\u20135561. https:\/\/doi.org\/10.1111\/jcmm.17572 (2022).","journal-title":"J. Cell. Mol. Med."},{"issue":"6220","key":"46674_CR14","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347 (6220), 1260419. https:\/\/doi.org\/10.1126\/science.1260419 (2015).","journal-title":"Science"},{"issue":"13","key":"46674_CR15","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184 (13), 3573\u20133587e29. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048 (2021).","journal-title":"Cell"},{"issue":"4","key":"46674_CR16","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S., Murrow, L. M., Gartner, Z. J. & DoubletFinder Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell. Syst. 8 (4), 329\u2013337e4. https:\/\/doi.org\/10.1016\/j.cels.2019.03.003 (2019).","journal-title":"Cell. Syst."},{"issue":"2","key":"46674_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00432-023-05592-3","volume":"150","author":"W Cui","year":"2024","unstructured":"Cui, W. et al. Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer. J. Cancer Res. Clin. Oncol. 150 (2), 47. https:\/\/doi.org\/10.1007\/s00432-023-05592-3 (2024).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"46674_CR18","doi-asserted-by":"publisher","first-page":"597835","DOI":"10.3389\/fcell.2020.597835","volume":"8","author":"T Shimizu","year":"2020","unstructured":"Shimizu, T., Fujii, T. & Sakai, H. The Relationship Between Actin Cytoskeleton and Membrane Transporters in Cisplatin Resistance of Cancer Cells. Front. Cell. Dev. Biol. 8, 597835. https:\/\/doi.org\/10.3389\/fcell.2020.597835 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"issue":"2","key":"46674_CR19","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.18632\/oncotarget.13734","volume":"8","author":"L Su","year":"2017","unstructured":"Su, L. et al. Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar. Oncotarget 8 (2), 2617\u20132627. https:\/\/doi.org\/10.18632\/oncotarget.13734 (2017).","journal-title":"Oncotarget"},{"issue":"5","key":"46674_CR20","doi-asserted-by":"publisher","first-page":"462","DOI":"10.15252\/embj.201592081","volume":"35","author":"MH Kim","year":"2016","unstructured":"Kim, M. H. et al. Actin remodeling confers BRAF inhibitor resistance to melanoma cells through YAP\/TAZ activation. EMBO J. 35 (5), 462\u2013478. https:\/\/doi.org\/10.15252\/embj.201592081 (2016).","journal-title":"EMBO J."},{"issue":"4","key":"46674_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.bcp.2007.10.010","volume":"75","author":"KS Ahn","year":"2008","unstructured":"Ahn, K. S., Sethi, G. & Aggarwal, B. B. Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-kappaB pathway. Biochem. Pharmacol. 75 (4), 907\u2013913. https:\/\/doi.org\/10.1016\/j.bcp.2007.10.010 (2008).","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"46674_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.trecan.2017.01.004","volume":"3","author":"A L\u00f3pez-Soto","year":"2017","unstructured":"L\u00f3pez-Soto, A., Gonzalez, S. & Folgueras, A. R. IFN Signaling and ICB Resistance: Time is on Tumor\u2019s Side. Trends Cancer. 3 (3), 161\u2013163. https:\/\/doi.org\/10.1016\/j.trecan.2017.01.004 (2017).","journal-title":"Trends Cancer"},{"issue":"2","key":"46674_CR23","doi-asserted-by":"publisher","first-page":"e521","DOI":"10.1038\/cddis.2013.42","volume":"4","author":"J Park","year":"2013","unstructured":"Park, J. et al. TGF-\u03b21 and hypoxia-dependent expression of MKP-1 leads tumor resistance to death receptor-mediated cell death. Cell. Death Dis. 4 (2), e521. https:\/\/doi.org\/10.1038\/cddis.2013.42 (2013).","journal-title":"Cell. Death Dis."},{"key":"46674_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2025.05.004","volume":"85","author":"W Luo","year":"2025","unstructured":"Luo, W. et al. TGF-\u03b2-driven EMT in cancer progression and drug resistance. Cytokine Growth Factor. Rev. 85, 11\u201325. https:\/\/doi.org\/10.1016\/j.cytogfr.2025.05.004 (2025).","journal-title":"Cytokine Growth Factor. Rev."},{"issue":"11","key":"46674_CR25","doi-asserted-by":"publisher","first-page":"e2415869122","DOI":"10.1073\/pnas.2415869122","volume":"122","author":"M Cao","year":"2025","unstructured":"Cao, M. et al. p53 activates circASCC3 to repress R-loops and enhance resistance to chemotherapy. Proc. Natl. Acad. Sci. U S A. 122 (11), e2415869122. https:\/\/doi.org\/10.1073\/pnas.2415869122 (2025).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"8","key":"46674_CR26","doi-asserted-by":"publisher","first-page":"114543","DOI":"10.1016\/j.celrep.2024.114543","volume":"43","author":"JN Joshi","year":"2024","unstructured":"Joshi, J. N. et al. mTORC1 activity oscillates throughout the cell cycle, promoting mitotic entry and differentially influencing autophagy induction. Cell. Rep. 43 (8), 114543. https:\/\/doi.org\/10.1016\/j.celrep.2024.114543 (2024).","journal-title":"Cell. Rep."},{"issue":"1","key":"46674_CR27","doi-asserted-by":"publisher","first-page":"17115","DOI":"10.1038\/s41598-020-74278-4","volume":"10","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. & Dong, F. Gfi1 upregulates c-Myc expression and promotes c-Myc-driven cell proliferation. Sci. Rep. 10 (1), 17115. https:\/\/doi.org\/10.1038\/s41598-020-74278-4 (2020).","journal-title":"Sci. Rep."},{"issue":"12","key":"46674_CR28","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.3390\/cancers14122928","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic. Cancers (Basel). 14 (12), 2928. https:\/\/doi.org\/10.3390\/cancers14122928 (2022).","journal-title":"Cancers (Basel)"},{"issue":"8","key":"46674_CR29","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/1878-0261.12965","volume":"15","author":"R Sreekumar","year":"2021","unstructured":"Sreekumar, R. et al. The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer. Mol. Oncol. 15 (8), 2065\u20132083. https:\/\/doi.org\/10.1002\/1878-0261.12965 (2021).","journal-title":"Mol. Oncol."},{"key":"46674_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fphar.2020.00343","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. Front. Pharmacol. 11, 343. https:\/\/doi.org\/10.3389\/fphar.2020.00343 (2020).","journal-title":"Front. Pharmacol."},{"issue":"8","key":"46674_CR31","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong, H. et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat. Med. 8 (8), 793\u2013800. https:\/\/doi.org\/10.1038\/nm730 (2002).","journal-title":"Nat. Med."},{"issue":"3","key":"46674_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman, Y. et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2 (3), 261\u2013268. https:\/\/doi.org\/10.1038\/85330 (2001).","journal-title":"Nat. Immunol."},{"key":"46674_CR33","doi-asserted-by":"publisher","first-page":"218219","DOI":"10.1016\/j.canlet.2025.218219","volume":"639","author":"F Wu","year":"2025","unstructured":"Wu, F. et al. HHLA2 promotes immune evasion in EGFR-mutant lung cancer by inhibiting CD8\u2009+\u2009T cell glutamine metabolism via KIR3DL3 interaction. Cancer Lett. 639, 218219. https:\/\/doi.org\/10.1016\/j.canlet.2025.218219 (2025).","journal-title":"Cancer Lett."},{"issue":"1","key":"46674_CR34","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13046-025-03514-4","volume":"44","author":"OJ Hussein","year":"2025","unstructured":"Hussein, O. J. et al. The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy. J. Exp. Clin. Cancer Res. 44 (1), 305. https:\/\/doi.org\/10.1186\/s13046-025-03514-4 (2025).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"46674_CR35","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2022.01.026","volume":"530","author":"TJ Li","year":"2022","unstructured":"Li, T. J. et al. SIGLEC15 amplifies immunosuppressive properties of tumor-associated macrophages in pancreatic cancer. Cancer Lett. 530, 142\u2013155. https:\/\/doi.org\/10.1016\/j.canlet.2022.01.026 (2022).","journal-title":"Cancer Lett."},{"issue":"12","key":"46674_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/membranes15120381","volume":"15","author":"PHS de Oliveira","year":"2025","unstructured":"de Oliveira, P. H. S., Silva-Freitas, B. B. & Meyer-Fernandes, J. R. Hypoxia as a Central Regulator of Plasma Membrane Phosphohydrolase Enzymes: Possible Roles in Extracellular Phosphate Generation and Adenosine Metabolism. Membr. (Basel). 15 (12), 381. https:\/\/doi.org\/10.3390\/membranes15120381 (2025).","journal-title":"Membr. (Basel)"},{"issue":"12","key":"46674_CR37","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3390\/pathogens14121233","volume":"14","author":"N Nikoli\u0107","year":"2025","unstructured":"Nikoli\u0107, N. et al. Oral Microbiota and Carcinogenesis: Exploring the Systemic Impact of Oral Pathogens. Pathogens 14 (12), 1233. https:\/\/doi.org\/10.3390\/pathogens14121233 (2025).","journal-title":"Pathogens"},{"key":"46674_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02534-0","author":"J Ye","year":"2025","unstructured":"Ye, J. et al. Targeting the CD47-HCK-LGALS9 axis disrupts proliferation-immunosuppression coupling in early-stage endometrial cancer. Mol. Cancer. (2025). https:\/\/doi.org\/10.1186\/s12943-025-02534-0","journal-title":"Mol. Cancer"},{"issue":"12","key":"46674_CR39","doi-asserted-by":"publisher","first-page":"e013283","DOI":"10.1136\/jitc-2025-013283","volume":"13","author":"L Nan","year":"2025","unstructured":"Nan, L. et al. Harnessing the innate immune system: a novel bispecific antibody targeting CD47 and CD24 for selective tumor clearance. J. Immunother Cancer. 13 (12), e013283. https:\/\/doi.org\/10.1136\/jitc-2025-013283 (2025).","journal-title":"J. Immunother Cancer"},{"key":"46674_CR40","doi-asserted-by":"publisher","first-page":"1716778","DOI":"10.3389\/fimmu.2025.1716778","volume":"16","author":"X Beli","year":"2025","unstructured":"Beli, X. et al. Harnessing the immunomodulatory properties of HLA-G for advanced immunotherapies. Front. Immunol. 16, 1716778. https:\/\/doi.org\/10.3389\/fimmu.2025.1716778 (2025).","journal-title":"Front. Immunol."},{"issue":"6","key":"46674_CR41","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich, J. D. et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 185 (6), 3190\u20133198. https:\/\/doi.org\/10.4049\/jimmunol.0903670 (2010).","journal-title":"J. Immunol."},{"issue":"1","key":"46674_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng, Z. et al. TGF-\u03b2 signaling in health, disease, and therapeutics. Signal. Transduct. Target. Ther. 9 (1), 61. https:\/\/doi.org\/10.1038\/s41392-024-01764-w (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"46674_CR43","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1007\/s12672-025-03868-3","volume":"16","author":"S Hong","year":"2025","unstructured":"Hong, S. et al. Exploration of the roles of CAFs in melanoma based on single-cell transcriptomics and spatial transcriptomics. Discov Oncol. 16 (1), 2105. https:\/\/doi.org\/10.1007\/s12672-025-03868-3 (2025).","journal-title":"Discov Oncol."},{"issue":"3","key":"46674_CR44","doi-asserted-by":"publisher","first-page":"25203","DOI":"10.31083\/FBL25203","volume":"30","author":"JF Santibanez","year":"2025","unstructured":"Santibanez, J. F. Myeloid-Derived Suppressor Cells: Implications in Cancer Immunology and Immunotherapy. Front. Biosci. (Landmark Ed). 30 (3), 25203. https:\/\/doi.org\/10.31083\/FBL25203 (2025).","journal-title":"Front. Biosci. (Landmark Ed)"},{"issue":"1","key":"46674_CR45","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu, B., Zhang, B., Li, B., Wu, H. & Jiang, M. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal. Transduct. Target. Ther. 9 (1), 274. https:\/\/doi.org\/10.1038\/s41392-024-01979-x (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"6322","key":"46674_CR46","doi-asserted-by":"publisher","first-page":"eaaf8399","DOI":"10.1126\/science.aaf8399","volume":"355","author":"T Davoli","year":"2017","unstructured":"Davoli, T. et al. Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science 355 (6322), eaaf8399. https:\/\/doi.org\/10.1126\/science.aaf8399 (2017).","journal-title":"Science"},{"issue":"8","key":"46674_CR47","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41588-018-0165-1","volume":"50","author":"CM Bielski","year":"2018","unstructured":"Bielski, C. M. et al. Genome doubling shapes the evolution and prognosis of advanced cancers. Nat. Genet. 50 (8), 1189\u20131195. https:\/\/doi.org\/10.1038\/s41588-018-0165-1 (2018).","journal-title":"Nat. Genet."},{"issue":"1","key":"46674_CR48","doi-asserted-by":"publisher","first-page":"188661","DOI":"10.1016\/j.bbcan.2021.188661","volume":"1877","author":"M Chen","year":"2022","unstructured":"Chen, M., Linstra, R. & van Vugt, M. A. T. M. Genomic instability, inflammatory signaling and response to cancer immunotherapy. Biochim. Biophys. Acta Rev. Cancer. 1877 (1), 188661. https:\/\/doi.org\/10.1016\/j.bbcan.2021.188661 (2022).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"5","key":"46674_CR49","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1158\/0008-5472.CAN-10-3604","volume":"71","author":"AJ Lee","year":"2011","unstructured":"Lee, A. J. et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res. 71 (5), 1858\u20131870. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3604 (2011).","journal-title":"Cancer Res."},{"issue":"1","key":"46674_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier, J. S. & Cheresh, D. A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer. 10 (1), 9\u201322. https:\/\/doi.org\/10.1038\/nrc2748 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"46674_CR51","doi-asserted-by":"publisher","first-page":"1145300","DOI":"10.3389\/fimmu.2023.1145300","volume":"14","author":"X Yu","year":"2023","unstructured":"Yu, X. et al. Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma. Front. Immunol. 14, 1145300. https:\/\/doi.org\/10.3389\/fimmu.2023.1145300 (2023).","journal-title":"Front. Immunol."},{"issue":"8","key":"46674_CR52","doi-asserted-by":"publisher","first-page":"442","DOI":"10.21037\/atm-22-1134","volume":"10","author":"Z Ji","year":"2022","unstructured":"Ji, Z. et al. Molecular characterization of vascular intestinal obstruction using whole-exome sequencing. Ann. Transl Med. 10 (8), 442. https:\/\/doi.org\/10.21037\/atm-22-1134 (2022).","journal-title":"Ann. Transl Med."},{"issue":"D1","key":"46674_CR53","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"46674_CR54","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"46674_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"46674_CR56","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1093\/oncolo\/oyae013","volume":"29","author":"DC Guven","year":"2024","unstructured":"Guven, D. C. et al. The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review. Oncologist 29 (5), e580\u2013e600. https:\/\/doi.org\/10.1093\/oncolo\/oyae013 (2024).","journal-title":"Oncologist"},{"key":"46674_CR57","doi-asserted-by":"publisher","first-page":"1112276","DOI":"10.3389\/fonc.2023.1112276","volume":"13","author":"J Ros","year":"2023","unstructured":"Ros, J. et al. Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer. Front. Oncol. 13, 1112276. https:\/\/doi.org\/10.3389\/fonc.2023.1112276 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"46674_CR58","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41420-024-02126-9","volume":"10","author":"B Li","year":"2024","unstructured":"Li, B., Mi, J. & Yuan, Q. Fatty acid metabolism-related enzymes in colorectal cancer metastasis: from biological function to molecular mechanism. Cell. Death Discov. 10 (1), 350. https:\/\/doi.org\/10.1038\/s41420-024-02126-9 (2024).","journal-title":"Cell. Death Discov"},{"issue":"1","key":"46674_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41420-024-01865-z","volume":"10","author":"X Chen","year":"2024","unstructured":"Chen, X. et al. The effects of metabolism on the immune microenvironment in colorectal cancer. Cell. Death Discov. 10 (1), 118. https:\/\/doi.org\/10.1038\/s41420-024-01865-z (2024).","journal-title":"Cell. Death Discov"},{"issue":"1","key":"46674_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang, A. et al. Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol. Cancer. 23 (1), 251. https:\/\/doi.org\/10.1186\/s12943-024-02156-y (2024).","journal-title":"Mol. Cancer"},{"issue":"8","key":"46674_CR61","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1158\/0008-5472.CAN-23-2123","volume":"84","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. Th17 Cells Secrete TWEAK to Trigger Epithelial-Mesenchymal Transition and Promote Colorectal Cancer Liver Metastasis. Cancer Res. 84 (8), 1352\u20131371. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2123 (2024).","journal-title":"Cancer Res."},{"issue":"2","key":"46674_CR62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31 (2), 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334 (2010).","journal-title":"J. Comput. Chem."},{"issue":"8","key":"46674_CR63","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1172\/JCI127201","volume":"129","author":"Y Cao","year":"2019","unstructured":"Cao, Y. Adipocyte and lipid metabolism in cancer drug resistance. J. Clin. Invest. 129 (8), 3006\u20133017. https:\/\/doi.org\/10.1172\/JCI127201 (2019).","journal-title":"J. Clin. Invest."},{"issue":"1","key":"46674_CR64","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia, S., Vasseur, S. & Guillaumond, F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5 (1), e189. https:\/\/doi.org\/10.1038\/oncsis.2015.49 (2016).","journal-title":"Oncogenesis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46674-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46674-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T09:46:53Z","timestamp":1783072013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46674-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,3]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46674"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46674-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,3]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article, affiliation 2 was incorrectly given as \u201cDepartment of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, Shanxi, China.\u201d The correct affiliation is \u201cCancer Hospital Affiliated to Shanxi Medical University, Department of Pathology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Taiyuan 030013, Shanxi, China.\u201d","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Shanxi Provincial Cancer Hospital (No.202112).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15900"}}